Cargando…

Patient-Reported Quality of Life Outcomes after Moderately Hypofractionated and Normofractionated Proton Therapy for Localized Prostate Cancer

SIMPLE SUMMARY: For patients with localized prostate cancer (PCa), information on the quality of life (QOL) after treatment is important when determining their preferred treatment option. In external beam radiation therapy, moderate hypofractionation (MH) is becoming an alternative standard for PCa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakajima, Koichiro, Iwata, Hiromitsu, Hattori, Yukiko, Nomura, Kento, Hayashi, Kensuke, Toshito, Toshiyuki, Umemoto, Yukihiro, Hashimoto, Shingo, Ogino, Hiroyuki, Shibamoto, Yuta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833499/ https://www.ncbi.nlm.nih.gov/pubmed/35158785 http://dx.doi.org/10.3390/cancers14030517

Ejemplares similares

Changes in sexual function and serum testosterone levels in patients with prostate cancer after image-guided proton therapy
por: Hattori, Yukiko, et al.
Publicado: (2021)

Spot Scanning Proton Therapy for Sinonasal Malignant Tumors
por: Nakajima, Koichiro, et al.
Publicado: (2021)

Image-Guided Proton Therapy for Elderly Patients with Hepatocellular Carcinoma: High Local Control and Quality of Life Preservation
por: Iwata, Hiromitsu, et al.
Publicado: (2021)

Outcomes of proton therapy for non-small cell lung cancer in patients with interstitial pneumonia
por: Hashimoto, Shingo, et al.
Publicado: (2022)

Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer
por: Nakajima, Koichiro, et al.
Publicado: (2018)

Proton therapy for non-squamous cell carcinoma of the head and neck: planning comparison and toxicity
por: Iwata, Hiromitsu, et al.
Publicado: (2019)

Compatibility of the repairable-conditionally repairable, multi-target and linear-quadratic models in converting hypofractionated radiation doses to single doses
por: Iwata, Hiromitsu, et al.
Publicado: (2013)

Whole-pelvic radiotherapy with spot-scanning proton beams for uterine cervical cancer: a planning study
por: Hashimoto, Shingo, et al.
Publicado: (2016)

Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomes
por: Pelak, Maciej J., et al.
Publicado: (2022)

Combined effects of cisplatin and photon or proton irradiation in cultured cells: radiosensitization, patterns of cell death and cell cycle distribution
por: Iwata, Hiromitsu, et al.
Publicado: (2020)

Effectiveness of hypofractionated and normofractionated radiotherapy in a triple‐negative breast cancer model
por: Grosche, Sinja, et al.
Publicado: (2022)

Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
por: Shibamoto, Yuta, et al.
Publicado: (2016)

CyberKnife Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy As First-line Treatments for Imaging-diagnosed Intracranial Meningiomas
por: MANABE, Yoshihiko, et al.
Publicado: (2017)

A Comprehensive Prospective Comparison of Acute Skin Toxicity after Hypofractionated and Normofractionated Radiation Therapy in Breast Cancer
por: Borm, Kai J., et al.
Publicado: (2021)

Favorable safety profile of moderate hypofractionated over normofractionated radiotherapy in breast cancer patients: a multicentric prospective real-life data farming analysis
por: Issoufaly, Irfane, et al.
Publicado: (2022)

Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis
por: Alfredo, Conti, et al.
Publicado: (2019)

Comparison of multileaf collimator and conventional circular collimator systems in Cyberknife stereotactic radiotherapy
por: Murai, Taro, et al.
Publicado: (2017)

Correction to: Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis
por: Conti, Alfredo, et al.
Publicado: (2020)

Efficacy of the Dynamic Jaw Mode in Helical Tomotherapy With Static Ports for Breast Cancer
por: Sugie, Chikao, et al.
Publicado: (2015)

Prospective Comparison of Hypofractionated Versus Normofractionated Intensity-Modulated Radiotherapy in Breast Cancer: Late Toxicity Results of the Non-Inferiority KOSIMA Trial (ARO2010-3)
por: Sarria, Gustavo R., et al.
Publicado: (2022)

The Quest for Optimal Fractionation Schedules in Stereotactic Radiotherapy
por: Shibamoto, Yuta, et al.
Publicado: (2020)

Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT
por: Ogawa, Yasutaka, et al.
Publicado: (2018)

Dosimetric verification of IMPT using a commercial heterogeneous phantom
por: Yasui, Keisuke, et al.
Publicado: (2019)

Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines
por: Schatz, Julia, et al.
Publicado: (2022)

Moderate hypofractionation for prostate cancer
por: Arcangeli, Stefano, et al.
Publicado: (2017)

Moderate hypofractionation for prostate cancer
por: Lee, W. Robert, et al.
Publicado: (2018)

Treatment of Single or Multiple Brain Metastases by Hypofractionated Stereotactic Radiotherapy Using Helical Tomotherapy
por: Nagai, Aiko, et al.
Publicado: (2014)

Percutaneous fiducial marker placement under CT fluoroscopic guidance for stereotactic body radiotherapy of the lung: an initial experience
por: Ohta, Kengo, et al.
Publicado: (2013)

Percutaneous fiducial marker placement prior to stereotactic body radiotherapy for malignant liver tumors: an initial experience
por: Ohta, Kengo, et al.
Publicado: (2016)

Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
por: Lewitzki, Victor, et al.
Publicado: (2019)

Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis
por: Klement, Rainer J., et al.
Publicado: (2021)

Applicability of the linear–quadratic model to single and fractionated radiotherapy schedules: an experimental study
por: Miyakawa, Akifumi, et al.
Publicado: (2014)

MMAP-08 CHEMO-REIRRADIATION (NORMOFRACTIONATED VS. HYPOFRACTIONATED) WITH OR WITHOUT BEVACIZUMAB IN RECURRENT ADULT DIFFUSE HIGH-GRADE GLIOMA (COBRA): PHASE III RANDOMIZED CONTROLLED TRIAL WITH A 2 X 2 FACTORIAL DESIGN
por: Baviskar, Yamini, et al.
Publicado: (2022)

Organizing pneumonia after stereotactic ablative radiotherapy of the lung
por: Murai, Taro, et al.
Publicado: (2012)

Impact on dose distribution and volume changes of a bioabsorbable polyglycolic acid spacer during chemo-proton therapy for a pediatric Ewing sarcoma
por: Kimura, Mitsuhiro, et al.
Publicado: (2020)

Comparison of intensity-modulated radiotherapy with the 5-field technique, helical tomotherapy and volumetric modulated arc therapy for localized prostate cancer
por: Kita, Nozomi, et al.
Publicado: (2022)

Acute toxicity and patient‐reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer
por: Iizumi, Takashi, et al.
Publicado: (2021)

Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy
por: Cui, Ming, et al.
Publicado: (2022)

Dose–volume histogram comparison between static 5-field IMRT with 18-MV X-rays and helical tomotherapy with 6-MV X-rays
por: Hayashi, Akihiro, et al.
Publicado: (2015)

Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qq7aqau0d752qnb05tgq55l6de